US2011306617A1PendingUtilityA1
Methods and Compositions for the Production of High Concentration Alloxazine Solutions
Est. expiryJan 27, 2026(expired)· nominal 20-yr term from priority
A61P 7/00A01N 43/90A61P 31/00A61P 43/00C07D 475/14A61K 31/525A01N 1/126A01N 1/10A61L 2/00A61L 2/10Y02A50/30
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods are provided for preparation of compositions having an enhanced level of soluble alloxazine, as compared to compositions prepared using conventional techniques. Compositions and a riboflavin form having higher solubility in solution is also provided.
Claims
exact text as granted — not AI-modified1 . A composition for treating a blood product comprising:
between about 150 μM and about 580 μM soluble alloxazine; and a monovalent salt.
2 . The composition of claim 1 wherein the soluble alloxazine is a concentration of about 580 μM.
3 . The composition of claim 1 wherein the alloxazine is riboflavin.
4 . The composition of claim 1 further comprising sodium bicarbonate.
5 . The composition of claim 1 wherein the composition has a pH of from about 4 to about 5.
6 . The composition of claim 1 wherein the monovalent salt provides a salinity of at least 0.9%.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.